Skip to main content

Advertisement

Open Peer Review Reports for: Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
21 Nov 2010 Submitted Original manuscript
2 Dec 2010 Author responded Author comments - Eva Johanna Kantelhardt
Resubmission - Version 2
2 Dec 2010 Submitted Manuscript version 2
13 Dec 2010 Author responded Author comments - Eva Johanna Kantelhardt
Resubmission - Version 3
13 Dec 2010 Submitted Manuscript version 3
15 Feb 2011 Reviewed Reviewer Report - Michael Dixon
1 Mar 2011 Author responded Author comments - Eva Johanna Kantelhardt
Resubmission - Version 4
1 Mar 2011 Submitted Manuscript version 4
11 Mar 2011 Author responded Author comments - Eva Johanna Kantelhardt
Resubmission - Version 5
11 Mar 2011 Submitted Manuscript version 5
19 Mar 2011 Author responded Author comments - Eva Johanna Kantelhardt
Resubmission - Version 6
19 Mar 2011 Submitted Manuscript version 6
Publishing
16 Apr 2011 Editorially accepted
16 Apr 2011 Article published 10.1186/1471-2407-11-140

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement